DARDEN vs BF.B
BF.B wins the Tale of the Tape 1–0.
🏆 Tale of the Tape
Green = winner in each category. Higher is better except P/E (lower = cheaper).
Fundamentals
| Metric | DARDEN | BF.B |
|---|---|---|
| Market Cap | — | $11.8B |
| P/E Ratio | — | 15.0x |
| Forward P/E | — | 15.2x |
| P/B | — | 2.89x |
| Dividend Yield | — | 3.58% |
| Beta | — | 0.35 |
Quantitative Metrics
| Metric | DARDEN | BF.B |
|---|---|---|
| DCF Fair Value | — | — |
| DCF Upside | — | — |
| Piotroski F | — | — |
| Altman Z | — | — |
| Beneish M | — | — |
| FCF Yield | — | — |
| Net Debt/EBITDA | — | — |
| ROIC | — | — |
| WACC | — | — |
| ROIC – WACC | — | — |
| Gross Margin | — | — |
| Net Margin | — | — |
| Rev Growth YoY | — | — |
| Sharpe (1Y) | — | — |
| Max Drawdown 3Y | — | — |
| FCF Payout Ratio | — | — |
DARDEN Price
BF.B Price
ETF Exposure
More Comparisons
Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.
DARDEN vs BF.B: Head-to-Head Analysis
DARDEN (DARDEN) and BF.B (BF.B) represent companies in different sectors. In our quantitative Tale of the Tape scoring, BF.B leads 1–0 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.
BF.B appears in 15 ETFs.
Frequently Asked Questions
Which stock is the better investment, DARDEN or BF.B?
Our quantitative analysis compares DARDEN and BF.B across nine fundamental dimensions. BF.B wins the Tale of the Tape 1–0. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.
Are DARDEN and BF.B correlated?
Correlation data is not yet available for this pair. Check back after both stocks have sufficient trading history.
How is the Tale of the Tape scored?
The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.